Related Experiment Video
Updated: Jun 26, 2026

08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Modeling, Analysis, and Optimal Control of Leukemic Cell Population Dynamics Under Therapy
Pauline Mazel1,2, Frédéric Grognard3, Thomas Stiehl4,5,6
1Université Côte d'Azur, Inria, INRAE, CNRS, MACBES, Valbonne, France. pauline.mazel@inria.fr.
Bulletin of Mathematical Biology
|June 24, 2026
Summary
This study extends a mathematical model of leukemia cell dynamics to include chemotherapy effects. The research optimizes anti-cancer strategies by minimizing leukemia stem cells and drug toxicity, revealing a complex system with potential for novel therapeutic approaches.
Area of Science:
- Mathematical Biology
- Computational Oncology
- Systems Biology
Background:
- Existing ordinary differential equation (ODE) models describe healthy and leukemic cell dynamics.
- Chemotherapy's impact on these dynamics requires a more refined mathematical framework.
Purpose of the Study:
- To extend an existing ODE model by incorporating a chemotherapy control variable.
- To establish a mathematical basis for investigating anti-cancer strategies.
- To optimize chemotherapy regimens for minimizing leukemia stem cells and drug toxicity.
Main Methods:
- Stability analysis of system equilibria using clinical data.
- Optimal control problem formulation using Pontryagin's Maximum Principle.
- Direct numerical optimization and sensitivity analysis.
Main Results:
- Identification of a complex equilibrium structure, including a continuum of coexistence states and bifurcation thresholds.
- Demonstration of a turnpike phenomenon where dynamic trajectories approach ideal static structures over time.
- Sensitivity analysis providing insights into biological mechanisms influencing optimal therapeutic outcomes.
Conclusions:
- The extended framework offers a refined mathematical basis for anti-cancer strategy investigation.
- The study highlights unconventional features in optimal control problems due to complex equilibria.
- Findings suggest potential for improved chemotherapy optimization based on identified biological mechanisms.

